Skip to Main content Skip to Navigation
Journal articles

Targeted Based Therapies in Metastatic Breast Cancer: Future Evolution

Abstract : Targeted Based Therapies in Metastatic Breast Cancer: Future Evolution. Research on molecular alteration process mechanisms leading to cancerogenesis permitted the elaboration of many targeted therapies. Some therapeutic classes appeared recently and are currently being tested, including HER-2 dimerization inhibitors. However, most of these therapies are mostly ineffective with monotherapy. Clinical trials are ongoing, testing their efficiency in association with other molecules of the therapeutic arsenal which is available in oncology. Nevertheless, breast cancer remains a pathology life-threatening, most of the time. Within this review will be introduced the most efficient of these targeted therapies, including their eventual association with other cytotoxic molecules.
Document type :
Journal articles
Complete list of metadatas

https://hal-amu.archives-ouvertes.fr/hal-01460351
Contributor : Didier Gigmes <>
Submitted on : Tuesday, February 7, 2017 - 4:35:05 PM
Last modification on : Wednesday, August 19, 2020 - 12:08:19 PM

Links full text

Identifiers

Collections

Citation

Laure Belmondo, Marc Montana, Christophe Curti, Maxime Crozet, Pascal Rathelot, et al.. Targeted Based Therapies in Metastatic Breast Cancer: Future Evolution. Thérapie, EDP Sciences, 2012, 67 (6), pp.491--503. ⟨10.2515/therapie/2012068⟩. ⟨hal-01460351⟩

Share

Metrics

Record views

123